Denice Torres - 02 Aug 2021 Form 4 Insider Report for Surface Oncology, Inc.

Role
Director
Signature
/s/ Jessica Fees, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Aug 2021
Net transactions value
$0
Form type
4
Filing time
03 Aug 2021, 16:16:02 UTC
Previous filing
08 Jul 2021
Next filing
18 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +36,000 $0.000000 36,000 02 Aug 2021 Common Stock 36,000 $6.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest ratably over three years following July 6, 2021, so long as the grantee remains a director or other service provider of the Company on such dates.